Entourage Effect Capital is a private investment firm primarily focused on the cannabis industry, investing across its entire value chain. Their strategy involves identifying, investing in, and accelerating high-quality emerging growth companies, with a particular emphasis on building scale in later-stage cannabis companies in anticipation of federal legalization in the U.S.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is growth (50% of deals).
Portfolio
2
Fund Size
$350M
Top Stage
Growth
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Phylos | Growth | $7.6M | Feb 2022 |
 Cellibre Inc. | Series A | $11.5M | Oct 2021 |
Top Co-Investors
Last updated: 28 April 2026